Skip to main content

Cavu Management, LP's Form 4 filing

IN8BIO, Inc. (INAB) · filed Dec 14, 2023

Accession no.
0001104659-23-125830
Filed
Dec 14, 2023, 6:03 AM ET
Trade date
Dec 13, 2023
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 3 derivative transactions. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Cavu Management, LPCIK 000181327010% Owner
Cavu Advisors, LLCCIK 000181331010% Owner
BP Directors, LPCIK 000181331110% Owner
Bios Equity Partners II, LPCIK 000181331310% Owner
Bios Equity Partners, LPCIK 000181331410% Owner
Kreis Leslie W.CIK 000181331610% Owner
BIOS Equity Partners III, LPCIK 000183197610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

This filing has no transactions of this kind.

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 13, 2023Common StockPPurchaseAcquired+574,241––574,241IndirectDuplicate filing
Dec 13, 2023Common StockPPurchaseAcquired+574,241––574,241IndirectDuplicate filing
Dec 13, 2023Common StockPPurchaseAcquired+574,241––574,241IndirectDuplicate filing

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)